 ROCKVILLE, Md. , Nov. 2, 2022 PRNewswire -- REGENXBIO Inc. Nasdaq: RGNX today announced it will participate in the following upcoming investor conferences: Credit Suisse 31st Annual Healthcare Conference Date: Tuesday, November 8, 2022 Location: Terranea Resort, Rancho Palos Verdes, CA Barclays Sixth Annual Barclays Gene EditingTherapy Summit Date: November 14, 2022 Panel Title: AAV Gene Therapy Current Status and Future Direction Panel Time: 2:50 p.m. 